Bank of America
CNTB

Bank of America’s Connect Biopharma Holdings CNTB Stock Holding History

Bank of America’s Portfolio CNTB Stock Details CNTB Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$41.1K Buy
+15,673
New +$40.9K ﹤0.01% 5622
2023
Q2 		– Sell
-2
Closed -$2 – 7735
2023
Q1 		$2 Sell
2
-10
-83% -$11 ﹤0.01% 7712
2022
Q4 		$10 Sell
12
-81
-87% -$67 ﹤0.01% 8076
2022
Q3 		$0 Sell
93
-409
-81% -$491 ﹤0.01% 7876
2022
Q2 		$0 Sell
502
-295,634
-100% -$435K ﹤0.01% 8055
2022
Q1 		$894K Buy
296,136
+9,007
+3% +$38K ﹤0.01% 5374
2021
Q4 		$1.48M Buy
287,129
+278,359
+3,174% +$3.09M ﹤0.01% 4861
2021
Q3 		$212K Buy
+8,770
New +$198K ﹤0.01% 6267

Other funds holding CNTB

IC
Ikarian Capital Dallas, Texas $1.23B AUM 600.17% 1-Year Est. Return
BFM
Boothbay Fund Management New York $7.71B AUM 106.29% 1-Year Est. Return
6CM
683 Capital Management New York $1.92B AUM 85.52% 1-Year Est. Return
PA
Perceptive Advisors New York $5.12B AUM 314.02% 1-Year Est. Return
ACM
ADAR1 Capital Management Austin, Texas $1.7B AUM 340.85% 1-Year Est. Return
RB
Richmond Brothers Jackson, Michigan $150M AUM 14.02% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
BCM
BML Capital Management Zionsville, Indiana $156M AUM 129.82% 1-Year Est. Return
DMKJ
David M. Knott Jr $168M AUM 60.36% 1-Year Est. Return
SCM
Stonepine Capital Management Bend, Oregon $250M AUM 77.6% 1-Year Est. Return

Bank of America's CNTB Position: Q1 2026 in Review

Bank of America opened a new position in Connect Biopharma Holdings (CNTB) in Q1 2026: 15,673 shares worth $41.1K. The stake represents ﹤0.01% of the portfolio and ranks #5622 among its holdings. This is a return to the name: Bank of America previously reported a position in CNTB as recently as Q1 2023.

Bank of America first reported a position in CNTB in Q3 2021 and has held it in 8 quarters since. The position peaked at $1.48M in Q4 2021. 41 funds tracked by Wall St. Rank hold CNTB as of Q1 2026.

  • Bank of America held 15,673 shares of Connect Biopharma Holdings worth $41.1K as of Q1 2026.
  • Connect Biopharma Holdings was a new Bank of America position in Q1 2026.
  • Connect Biopharma Holdings made up ﹤0.01% of Bank of America's portfolio in Q1 2026, its #5622 holding.
  • Bank of America first reported a position in Connect Biopharma Holdings in Q3 2021 and has held it in 8 quarters since.
  • Bank of America's Connect Biopharma Holdings position peaked at $1.48M in Q4 2021.
  • 41 funds tracked by Wall St. Rank held Connect Biopharma Holdings as of Q1 2026.

Based on Bank of America's 13F filing for Q1 2026, filed 18 May 2026.